The increasing demand for specific immunological investigation and therapeutic creation has spurred significant advances in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using multiple expression platforms, including microbial hosts, animal cell cultures, and